Podcasts

Podcast: The future of cell and gene therapies

by

Collaboration, supply chain resilience, acknowledgement they work, and trust will drive the cell and gene therapy sector going forward, EY’s Adlai Goldberg says on the latest episode of the BioProcess Insider Expression Platform. The cell and gene therapy sector is on the cusp of flourishing in the vast pharma landscape. Money is flowing in, manufacturing challenges are being overcome, people are actually being treated and cured. Even COVID-19 may be seen as a driving force for the burgeoning sector. But…

April 22, 2021

Podcast: Thermo Fisher on aseptic manufacturing in the time of COVID

by

In the latest episode of the BioProcess Insider Expression Platform, Thermo Fisher Scientific’s Vincenza Pironti discusses how vaccine and biologic makers can ensure a robust, global fill/finish supply both during the COVID pandemic and beyond. Vincenza Pironti – Global SME, Steriles, ThermoFisher Scientific – sat down (at a distance) with editor Dan Stanton to discuss aseptic manufacturing in the current climate as part of this year’s BIO-Europe Spring. The event took place last week, but if you missed it the…

March 30, 2021

Podcast: Content is king in bioprocessing and beyond

by

In the latest episode of the BioProcess Insider Expression System, Brian Caine (remember him) talks content, marketing, and communications in the biomanufacturing industry. Brian Caine, founder and publisher of our parent publication BioProcess International, stepped down from his position late last year to pursue new ventures. After a quarter of a century in the life sciences space, he speaks to us about the evolving publishing landscape and while he stresses ‘content is king,’ he warns that you cannot just print…

March 10, 2021

Podcast: Industry veteran moves to Lykan Bioscience, and this time its personal!

by

In the latest episode of the BioProcess Insider Expression Platform, we explore the evolution of cell and gene therapy production with new COO of Lykan Bioscience, Patrick Lucy. From Repligen, to Lonza, to Pfenex, Patrick Lucy has had an illustrious career. His latest career move is to Lykan Bioscience, a Massachusetts-based contract Manufacturing Services Organization (MSO) and provider of end-to-end solution for cell-based therapies, where he took on the role of chief operating officer (COO) in January. In this podcast,…

February 11, 2021

Podcast: Systemic racism in the biomanufacturing space

by

Black and minority workers are consistently overlooked in the biomanufacturing industry due to unconscious – or perhaps conscious – racism, LucasPye Bio CEO Tia Lyles-Williams explains in The BioProcess Insider Expression System podcast. In the first episode of this new podcast series, Tia-Lyles Williams, CEO of LucasPye Bio, talks about diversity in the biopharma workplace and the hurdles that continue to hold back black and minority workers. Tia now leads a Philadelphia-based CDMO that recently raised $50 million in funding…

January 22, 2021

Podcast: The impact of COVID-19 on the pharma and bio supply chain

by

Bioprocess Insider editor Dan Stanton joins an industry panel to discuss supply chain concerns stemming from the ongoing coronavirus crisis. Listen to the podcast now. Brought to you by international pharmaceutical content, digital and design agency ramarketing, the Molecule to Market podcast takes a listen to the contract outsourcing space with industry insights direct from the brains of the people that make the headlines. In this special episode, one of the headline writers – Bioprocess Insider founder and editor Dan…

October 26, 2020